KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Assets (2018 - 2025)

Historic Return on Assets for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to 0.3%.

  • Esperion Therapeutics' Return on Assets fell 1800.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.02% for FY2024, which is 9300.0% up from last year.
  • Per Esperion Therapeutics' latest filing, its Return on Assets stood at 0.3% for Q3 2025, which was down 1800.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Esperion Therapeutics' Return on Assets ranged from a high of 0.01% in Q4 2024 and a low of 1.22% during Q3 2021
  • In the last 5 years, Esperion Therapeutics' Return on Assets had a median value of 0.81% in 2022 and averaged 0.65%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -8700bps in 2021, then soared by 9900bps in 2024.
  • Quarter analysis of 5 years shows Esperion Therapeutics' Return on Assets stood at 0.9% in 2021, then increased by 6bps to 0.84% in 2022, then dropped by -19bps to 1.0% in 2023, then surged by 99bps to 0.01% in 2024, then tumbled by -1956bps to 0.3% in 2025.
  • Its Return on Assets stands at 0.3% for Q3 2025, versus 0.32% for Q2 2025 and 0.31% for Q1 2025.